文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

术后出院阿片类与非阿片类镇痛的系统综述与随机试验荟萃分析

Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis of randomised trials.
PubMed 文献 · Lancet · 2022-01-01
一句话结论择期小中型手术后出院时,阿片类处方不降低疼痛强度,却增加呕吐等不良事件;作者认为此类手术可考虑无阿片类镇痛。

该研究为系统综述与荟萃分析,检索1990年1月1日至2021年7月8日多个数据库,纳入47项多剂量随机对照试验、共6607例15岁及以上手术出院患者,比较阿片类与非阿片类镇痛。主要结局为出院后第1天疼痛强度(0-10 cm视觉模拟量表)和30天内呕吐。结果显示,阿片类处方未降低第1天疼痛(加权均数差0.01 cm,95%CI -0.26至0.27;中等确定性),也不影响其他术后时间点疼痛(中等至极低确定性);但呕吐风险增加(RR 4.50,95%CI 1.93至10.51;高确定性),恶心、便秘、头晕、嗜睡等其他不良事件亦增加(高至中等确定性)。作者认为,在择期小中型手术中可考虑无阿片类镇痛,但证据多来自低质量试验,且无大手术或重大复杂手术患者。

要点

  • 择期小中型手术出院时,阿片类处方不降低出院后第1天疼痛(加权均数差0.01 cm,95%CI -0.26至0.27;中等确定性)。
  • 阿片类处方增加呕吐风险(RR 4.50,95%CI 1.93至10.51;高确定性),并增加恶心、便秘、头晕、嗜睡(高至中等确定性)。
  • 作者认为,在择期小中型手术中可考虑无阿片类镇痛,但证据多来自低质量试验,且无大手术或重大复杂手术患者。
  • 47项试验中30项(64%)为择期小手术(63%牙科操作),17项(36%)为中等程度手术(47%骨科、29%普通外科)。

适用人群与场景

  • 年龄15岁及以上、按生理与手术严重度评分(POSSUM)定义接受小、中、大或重大复杂手术并出院的多剂量随机对照试验患者。
  • 纳入的47项试验中30项(64%)为择期小手术(其中63%为牙科操作),17项(36%)为中等程度手术(其中47%为骨科、29%为普通外科操作)。
  • 无大手术或重大复杂手术患者。

研究设计与关键结果

  • 系统综述与荟萃分析纳入47项多剂量随机对照试验、共6607例患者,比较手术出院后阿片类与非阿片类镇痛。
  • 与无阿片类镇痛相比,阿片类处方未降低出院后第1天疼痛强度(加权均数差0.01 cm,95%CI -0.26至0.27;中等确定性),也未降低其他术后时间点疼痛(中等至极低确定性)。
  • 阿片类处方与呕吐风险增加相关(RR 4.50,95%CI 1.93至10.51;高确定性),并增加恶心、便秘、头晕、嗜睡等其他不良事件(高至中等确定性)。
  • 阿片类对疼痛干扰、其他不良事件、不满意风险及再就诊率等其他结局无影响。

证据类型、等级与局限

  • 系统综述与随机对照试验荟萃分析,采用Cochrane随机试验偏倚风险评估工具双人评估,使用GRADE系统评价证据确定性,注册号PROSPERO CRD42020153050。
  • 证据多来自低质量试验,且无大手术或重大复杂手术患者,原文指出需提升该领域研究质量与范围。

对床旁实践的改变

  • 作者认为,在择期小中型手术中可考虑无阿片类镇痛;证据多来自低质量试验且无大手术或重大复杂手术患者。

指南或共识出处

  • 加拿大卫生研究院(Canadian Institutes of Health Research)资助。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Excessive opioid prescribing after surgery has contributed to the current opioid crisis; however, the value of prescribing opioids at surgical discharge remains uncertain. We aimed to estimate the extent to which opioid prescribing after discharge affects self-reported pain intensity and adverse events in comparison with an opioid-free analgesic regimen.

METHODS: In this systematic review and meta-analysis, we searched MEDLINE, Embase, the Cochrane Library, Scopus, AMED, Biosis, and CINAHL from Jan 1, 1990, until July 8, 2021. We included multidose randomised controlled trials comparing opioid versus opioid-free analgesia in patients aged 15 years or older, discharged after undergoing a surgical procedure according to the Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity definition (minor, moderate, major, and major complex). We screened articles, extracted data, and assessed risk of bias (Cochrane's risk-of-bias tool for randomised trials) in duplicate. The primary outcomes of interest were self-reported pain intensity on day 1 after discharge (standardised to 0-10 cm visual analogue scale) and vomiting up to 30 days. Pain intensity at further timepoints, pain interference, other adverse events, risk of dissatisfaction, and health-care reutilisation were also assessed. We did random-effects meta-analyses and appraised evidence certainty using the Grading of Recommendations, Assessment, Development, and Evaluations scoring system. The review was registered with PROSPERO (ID CRD42020153050).

FINDINGS: 47 trials (n=6607 patients) were included. 30 (64%) trials involved elective minor procedures (63% dental procedures) and 17 (36%) trials involved procedures of moderate extent (47% orthopaedic and 29% general surgery procedures). Compared with opioid-free analgesia, opioid prescribing did not reduce pain on the first day after discharge (weighted mean difference 0·01cm, 95% CI -0·26 to 0·27; moderate certainty) or at other postoperative timepoints (moderate-to-very-low certainty). Opioid prescribing was associated with increased risk of vomiting (relative risk 4·50, 95% CI 1·93 to 10·51; high certainty) and other adverse events, including nausea, constipation, dizziness, and drowsiness (high-to-moderate certainty). Opioids did not affect other outcomes.

INTERPRETATION: Findings from this meta-analysis support that opioid prescribing at surgical discharge does not reduce pain intensity but does increase adverse events. Evidence relied on trials focused on elective surgeries of minor and moderate extent, suggesting that clinicians can consider prescribing opioid-free analgesia in these surgical settings. Data were largely derived from low-quality trials, and none involved patients having major or major-complex procedures. Given these limitations, there is a great need to advance the quality and scope of research in this field.

FUNDING: The Canadian Institutes of Health Research.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Fiore JF, El-Kefraoui C, Chay MA, et al. Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis of randomised trials. Lancet. 2022. PMID: 35717988. doi:10.1016/S0140-6736(22)00582-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。